Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nathalie Largeron, Karl Ulrich Petry, Jorge Jacob, Florence Bianic, Delphine Anger & Mathieu Uhart. (2017) An estimate of the public health impact and cost-effectiveness of universal vaccination with a 9-valent HPV vaccine in Germany. Expert Review of Pharmacoeconomics & Outcomes Research 17:1, pages 85-98.
Read now
Read now
Barbara Romanowski, Tino F Schwarz, Linda Ferguson, Klaus Peters, Marc Dionne, Ulrich Behre, Karin Schulze, Peter Hillemanns, Pemmaraju Suryakiran, Florence Thomas & Frank Struyf. (2016) Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study. Human Vaccines & Immunotherapeutics 12:1, pages 20-29.
Read now
Read now
Cornelius Remschmidt, Dietmar Walter, Patrick Schmich, Matthias Wetzstein, Yvonne Deleré & Ole Wichmann. (2014) Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site. Human Vaccines & Immunotherapeutics 10:9, pages 2527-2535.
Read now
Read now
Sabrina Hense, Kathrin Hillebrand, Johannes Horn, Rafael Mikolajczyk, Renate Schulze-Rath & Edeltraut Garbe. (2014) HPV vaccine uptake after introduction of the vaccine in Germany. Human Vaccines & Immunotherapeutics 10:6, pages 1729-1733.
Read now
Read now
Articles from other publishers (15)
Genet Hailu, Desalegn Wirtu, Tariku Tesfaye & Motuma Getachew. (2023) Human papillomavirus vaccine uptake and associated factors among adolescent girls in high schools of Nekemte city, Western Ethiopia, 2020. BMC Women's Health 23:1.
Crossref
Crossref
Anna Loenenbach, Viktoria Schönfeld, Anja Takla, Miriam Wiese-Posselt, Adine Marquis, Sarah Thies, Matthias Sand, Andreas M. Kaufmann, Ole Wichmann & Thomas Harder. (2023) Human papillomavirus prevalence and vaccine effectiveness in young women in Germany, 2017/2018: results from a nationwide study. Frontiers in Public Health 11.
Crossref
Crossref
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin
e1
e39
.
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin
175
218
.
N. Rippinger, J. Heinzler, T. Bruckner, J. Brucker, C. Dinkic, J. Hoffmann, N. Dornhöfer, S. Seitz, J. Rom, C. Sohn, T. C. Schott & Sarah Schott. (2019) The impact of a cervical dysplasia diagnosis on individual cancer prevention habits over time: a bicentric case–control study. Archives of Gynecology and Obstetrics 299:3, pages 847-855.
Crossref
Crossref
Marc Arbyn, Lan Xu, Cindy Simoens & Pierre PL Martin-Hirsch. (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Crossref
Oliver Damm, Johannes Horn, Rafael T. Mikolajczyk, Mirjam E. E. Kretzschmar, Andreas M. Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer & Wolfgang Greiner. (2017) Cost-effectiveness of human papillomavirus vaccination in Germany. Cost Effectiveness and Resource Allocation 15:1.
Crossref
Crossref
Kathrin Thöne, Johannes Horn & Rafael Mikolajczyk. (2017) Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine—an interrupted time series analysis from 2005 to 2010 using health insurance data. BMC Infectious Diseases 17:1.
Crossref
Crossref
Stefanie Schülein, Katherine J. Taylor, Jochem König, Matthias Claus, Maria Blettner & Stefanie J. Klug. (2016) Factors influencing uptake of HPV vaccination among girls in Germany. BMC Public Health 16:1.
Crossref
Crossref
Ioannis N. Mammas, Maria Theodoridou, Chryssie Koutsaftiki, George Bertsias, George Sourvinos & Demetrios A. Spandidos. (2016) Vaccination against Human Papillomavirus in relation to Financial Crisis: The “Evaluation and Education of Greek Female Adolescents on Human Papillomaviruses’ Prevention Strategies” ELEFTHERIA Study. Journal of Pediatric and Adolescent Gynecology 29:4, pages 362-366.
Crossref
Crossref
IOANNIS N. MAMMAS, ANNE GREENOUGH, MARIA THEODORIDOU, ANNA KRAMVIS, ILIANA CHRISTAKI, CHRYSSIE KOUTSAFTIKI, MARIA KOUTSAKI, DIMITRA M. PORTALIOU, GEORGIA KOSTAGIANNI, PARASKEVI PANAGOPOULOU, GEORGE SOURVINOS & DEMETRIOS A. SPANDIDOS. (2016) Current views and advances on Paediatric Virology: An update for paediatric trainees. Experimental and Therapeutic Medicine 11:1, pages 6-14.
Crossref
Crossref
Cornelius Remschmidt, Michaela Fesenfeld, Andreas M Kaufmann & Yvonne Deleré. (2014) Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies. BMC Public Health 14:1.
Crossref
Crossref
Dietmar Walter, Patrick Schmich, Matthias Wetzstein, Deleré Yvonne, Ole Wichmann & Cornelius Remschmidt. (2014) Knowledge, attitude, and uptake related to human papillomavirus vaccination among young women in Germany recruited via a social media site. Human vaccines & immunotherapeutics 10:9.
Crossref
Crossref
Thorsten Rieck, Marcel Feig, Yvonne Deleré & Ole Wichmann. (2014) Utilization of administrative data to assess the association of an adolescent health check-up with human papillomavirus vaccine uptake in Germany. Vaccine 32:43, pages 5564-5569.
Crossref
Crossref
C. Poethko-Müller & N. Buttmann-Schweiger. (2014) Impfstatus und Determinanten der Impfung gegen humane Papillomviren (HPV) bei Mädchen in DeutschlandHPV vaccination coverage in German girls. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 57:7, pages 869-877.
Crossref
Crossref